tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Aquestive Therapeutics Inc

AQST
Add to Watchlist
3.695USD
-0.025-0.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
463.60MMarket Cap
LossP/E TTM

Aquestive Therapeutics Inc

3.695
-0.025-0.67%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

AQST Financials

See Aquestive Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Aquestive Therapeutics Inc Earnings Date

Latest Release
Aug 11, 2026
EPS / Forecast
--/-0.10
Revenue / Forecast
--/11.42M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
44.55M
-22.61%
EPS(YoY)
-0.78
-53.97%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
72.63%-0.07
-39.54%-0.26
-10.54%-0.14
-351.81%-0.14
-37.79%-0.24
-55.03%-0.19
-301.65%-0.13
70.11%-0.03
-220.16%-0.17
46.84%-0.12
---0.03
---0.10
--0.15
---0.23
---0.90
----
----
----
----
----
Revenue
65.67%14.45M
9.67%13.02M
-5.43%12.81M
-50.23%10.00M
-27.65%8.72M
-10.14%11.87M
4.15%13.54M
51.79%20.10M
8.25%12.05M
23.63%13.21M
13.43%13.00M
-0.18%13.24M
-9.26%11.13M
-3.57%10.68M
-13.73%11.46M
-13.55%13.27M
10.32%12.27M
54.96%11.08M
60.86%13.29M
-29.20%15.35M
Net Profit
64.86%-8.06M
-86.81%-31.86M
-34.21%-15.45M
-393.55%-13.55M
-78.75%-22.93M
-110.27%-17.05M
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
57.33%-12.35M
13.87%-12.54M
-31.82%-16.30M
9.90%-13.22M
-42.11%-28.95M
12.06%-14.55M
-429.86%-12.37M
Net Margin
78.79%-55.77%
-70.33%-244.79%
-41.91%-120.61%
-891.69%-135.44%
-147.07%-262.96%
-134.00%-143.72%
-443.00%-84.99%
68.78%-13.66%
-246.88%-106.43%
46.88%-61.42%
---15.65%
---43.74%
--72.46%
---115.63%
---113.68%
----
----
----
----
----
Gross Margin
30.74%75.99%
-10.91%55.16%
-3.60%64.82%
-29.78%54.40%
-8.60%58.12%
-4.12%61.91%
6.56%67.24%
54.88%77.48%
10.67%63.59%
28.27%64.57%
--63.10%
--50.03%
--57.45%
--50.34%
--61.94%
----
----
----
----
----
Debt to assets ratio
176.18%91.24%
145.84%78.84%
165.99%75.66%
46.37%37.38%
48.66%33.03%
-33.11%32.07%
-56.82%28.45%
-62.84%25.53%
-67.87%22.22%
-47.53%47.95%
--65.87%
--68.71%
--69.17%
--91.38%
--102.03%
----
----
----
----
----
Income Statement
Revenue
65.67%14.45M
9.67%13.02M
-5.43%12.81M
-50.23%10.00M
-27.65%8.72M
-10.14%11.87M
4.15%13.54M
51.79%20.10M
8.25%12.05M
23.63%13.21M
13.43%13.00M
-0.18%13.24M
-9.26%11.13M
-3.57%10.68M
-13.73%11.46M
-13.55%13.27M
10.32%12.27M
54.96%11.08M
60.86%13.29M
-29.20%15.35M
Operating profit
78.29%-4.20M
-112.38%-28.84M
-38.47%-11.48M
-20769.09%-11.37M
-116.20%-19.36M
-247.20%-13.58M
-248.76%-8.29M
101.31%55.00K
-94.51%-8.96M
63.49%-3.91M
73.15%-2.38M
67.02%-4.21M
52.71%-4.61M
8.19%-10.71M
-11.11%-8.85M
-95.83%-12.76M
-14.23%-9.74M
25.42%-11.67M
42.18%-7.97M
-1749.87%-6.52M
Net Profit
64.86%-8.06M
-86.81%-31.86M
-34.21%-15.45M
-393.55%-13.55M
-78.75%-22.93M
-110.27%-17.05M
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
57.33%-12.35M
13.87%-12.54M
-31.82%-16.30M
9.90%-13.22M
-42.11%-28.95M
12.06%-14.55M
-429.86%-12.37M
Balance Sheet
Current assets
46.00%130.18M
69.20%149.27M
57.06%151.67M
-21.43%81.72M
-21.35%89.17M
115.35%88.22M
127.45%96.57M
161.41%104.01M
159.41%113.38M
2.70%40.97M
11.47%42.46M
-8.54%39.79M
2.63%43.71M
-15.60%39.89M
-24.14%38.09M
-14.69%43.51M
-4.18%42.59M
5.90%47.26M
58.47%50.21M
16.14%51.00M
Total current liabilities
73.53%31.75M
152.36%47.61M
68.78%25.57M
66.64%23.16M
1.33%18.30M
3.04%18.86M
-37.02%15.15M
-64.05%13.89M
-55.28%18.06M
-53.68%18.31M
-34.20%24.06M
30.43%38.65M
66.98%40.38M
79.97%39.53M
46.01%36.56M
28.66%29.64M
20.62%24.18M
4.08%21.96M
36.28%25.04M
54.78%23.04M
Total assets
38.04%141.13M
58.17%160.43M
48.75%163.56M
-20.33%93.70M
-21.07%102.23M
76.64%101.42M
84.97%109.96M
106.35%117.61M
111.35%129.52M
0.61%57.42M
14.66%59.45M
1.21%56.99M
8.41%61.28M
-7.94%57.07M
-20.60%51.84M
-15.80%56.31M
-8.71%56.53M
-1.42%61.99M
29.49%65.29M
5.24%66.88M
Total liabilities
7.36%175.18M
20.12%194.09M
7.91%167.67M
8.63%166.29M
-1.60%163.16M
-1.42%161.58M
-4.31%155.38M
-6.45%153.08M
-2.75%165.82M
-6.67%163.91M
1.70%162.38M
7.19%163.65M
13.93%170.52M
21.85%175.62M
27.08%159.66M
26.54%152.67M
31.61%149.67M
29.40%144.13M
44.51%125.64M
42.04%120.64M
Total equity
44.11%-34.05M
44.04%-33.66M
90.95%-4.11M
-104.60%-72.59M
-67.85%-60.93M
43.51%-60.16M
55.87%-45.42M
66.73%-35.48M
66.77%-36.30M
10.18%-106.49M
4.54%-102.93M
-10.68%-106.65M
-17.28%-109.23M
-44.34%-118.55M
-78.67%-107.82M
-79.21%-96.36M
-79.82%-93.14M
-69.36%-82.13M
-65.24%-60.34M
-151.40%-53.77M
Cash Flow Statement
Net operating income
36.73%-14.81M
-30.51%-8.47M
-6.47%-12.65M
-12.96%-7.91M
-125.35%-23.40M
-31.30%-6.49M
-406.18%-11.88M
11.39%-7.01M
-217.79%-10.38M
-158.51%-4.94M
-183.55%-2.35M
-20.50%-7.91M
160.88%8.82M
204.78%8.45M
130.99%2.81M
-273.69%-6.56M
-2.73%-14.48M
40.34%-8.06M
-9.05%-9.06M
82.43%-1.76M
Net investment
61.48%-52.00K
-466.67%-85.00K
-193.75%-235.00K
-205.71%-107.00K
-365.52%-135.00K
6.25%-15.00K
47.02%-80.00K
95.76%-35.00K
-1350.00%-29.00K
38.46%-16.00K
91.21%-151.00K
-22.01%-826.00K
98.08%-2.00K
95.12%-26.00K
-1968.67%-1.72M
-248.97%-677.00K
-0.97%-104.00K
-125.85%-533.00K
-118.42%-83.00K
-73.21%-194.00K
Net financing
-78.58%4.42M
320.38%660.00K
478988.24%81.41M
-105.84%-100.00K
-74.74%20.65M
-95.99%157.00K
-100.34%-17.00K
-60.09%1.71M
988.01%81.74M
1818.14%3.91M
3707.97%4.98M
-57.96%4.29M
-809.17%-9.21M
-96.26%204.00K
-102.27%-138.00K
17.41%10.20M
-86.88%1.30M
-80.86%5.45M
86928.57%6.08M
86760.00%8.69M

FAQs

What is the total revenue of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its total revenue reached 44.55M, with a year-on-year change of 57.56M.

What are the current assets of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its current assets were 149.27M, with a year-on-year change of 69.20.

What are the total assets of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its total assets of Aquestive Therapeutics Inc were 160.43M, with a year-on-year change of 58.17.

What are the total liabilities of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its total liabilities of Aquestive Therapeutics Inc were 194.09M, with a year-on-year change of 20.12.

What is the total equity of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its total equity of Aquestive Therapeutics Inc was -33.66M, with a year-on-year change of 44.04.

What is the net operating income of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its net operating income of Aquestive Therapeutics Inc was -71.05M, with a year-on-year change of -130.90.

What is the net investment of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its net investment of Aquestive Therapeutics Inc was -562.00K, with a year-on-year change of -253.46.

What is the net financing of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its net financing of Aquestive Therapeutics Inc was 102.62M, with a year-on-year change of 22.76.

What is the Earnings Per Share (EPS) of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.78, with a year-on-year change of -53.97.

What is the net income of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its net income was -83.78M, with a year-on-year change of -89.83.

What is the net margin of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its net profit margin was -188.09, with a year-on-year change of -145.29.

What is the gross margin of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its gross margin was 58.35, with a year-on-year change of -15.38.

What is the debt-to-asset ratio of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 78.84, with a year-on-year change of -31.34.

What is the Return on Assets (ROA) of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -63.99, with a year-on-year change of -15.15.

What is the operating profit of Aquestive Therapeutics Inc?

According to Aquestive Therapeutics Inc's FY2025 earnings report, its operating profit was -71.05M, with a year-on-year change of -130.90.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy